Abstract. Genipin, an active constituent of Gardenia fruit, has been reported to show an antitumor effect in several cancer cell systems. Here, we demonstrate how genipin exhibits a strong apoptotic cell death effect in human non-small-cell lung cancer H1299 cells. Genipin-mediated decrease in cell viability was observed through apoptosis as demonstrated by induction of a sub-G 1 peak through flow cytometry, DNA fragmentation measured by TUNEL assay, and cleavage of poly ADP-ribose-polymerase. During genipin-induced apoptosis, the mitochondrial execution pathway was activated by caspase-9 and -3 activation as examined by a kinetic study, cytochrome c release, and a dose-dependent increase in Bax/Bcl-2 ratio. A search for the downstream pathway reveals that genipin-induced apoptosis was mediated by an increase in phosphorylated p38MAPK expression, which further activated downstream signaling by phosphorylating ATF-2. SB203580, a p38MAPK inhibitor, markedly blocked the formation of TUNEL-positive apoptotic cells in genipin-treated cells. Besides, the interference of p38MAPK inhibited Bax expression and cytochrome c release. Altogether, our observations imply that genipin causes increased levels of Bax in response to p38MAPK signaling, which results in the initiation of mitochondrial death cascade, and therefore it holds promise as a potential chemotherapeutic agent for the treatment of H1299 cells.
Introduction
Genipin, the aglycon of geniposide, is obtained from the fruit of Gardenia jasminoides ELLIS as a major active ingredient. It has long been used in traditional medicine formulations for treatment of inflammation and hepatic disorders (1, 2) . Genipin reacts spontaneously with amino acids to form blue pigments that are widely used in the food industry, and it is also an effective crosslinking reagent for biological tissue fixation (3) . In murine macrophage cells, genipin is an effective anti-inflammatory compound. Molecular studies have indicated that genipin attenuates mortality and organ injuries during sepsis through interference with TLR signaling (4) and inhibits the expression of iNOS and NO production through the NF-κB signaling pathway in LPS (lipo polysaccharide)-stimulated RAW264.7 cells (5) . Besides, genipin has been reported to possess various pharmacological properties such as antiangiogenic (6) , antithrombotic (7), anti-diabetic (8) , anti-oxidative (9) , and neurotrophic activities (10) . Notably, recent studies have shown that genipin inhibits growth and induces apoptosis in a variety of cell lines including FaO rat hepatoma cells, human hepatocarcinoma Hep3B cells (11) , PC3 human prostate cancer cells (12) , human HeLa cells (13) , and human leukemia K562 cells (14) . Hence, we studied whether genipin could exert the same anti-proliferative and pro-apoptotic effects on non-small-cell lung cancer (NSCLC) H1299 cells and the potential signaling pathway involved in these effects.
All eukaryotic cells possess multiple MAPK pathways, which coordinately regulate diverse cellular activities from gene expression, mitosis, and metabolism to motility, survival, and apoptosis, and differentiation (15) . MAPKs can be activated by a wide variety of different stimuli, but in general, ERK are preferentially activated by mitogenic stimuli such as growth factors, cytokines, and phorbol esters (16 -19) , while the JNK and p38MAPK kinases are more responsible to stress stimuli ranging from oxidative stress, UV irradiation, hypoxia, ischemia to various cytokines, including interleukin-1 (IL-1) and tumor necrosis factor-α (20 -25) . It has recently been reported that p38MAPK activity is associated with apoptotic induction in several cell types and in response to a multitude of cellular stresses (26) . Additionally, some studies suggest that there is a potential interaction between p38MAPK and the Bcl-2 family. P38MAPK can induce translocation of the pro-apoptotic protein Bax from the cytoplasm to mitochondria in mature neurons undergoing NO-induced apoptosis (27) . It has been shown that p38MAPK was required to induce a conformational change in Bax, thereby allowing for its translocation to mitochondria and cytochrome c release following UV damage (28) . In leukemic cells, p38MAPK promotes Withaferin A-induced apoptosis involved with an increase in Bax/Bcl-2 ratio, cytochrome c release, and caspase-9 and -3 activation (29) . This study was performed to test the hypothesis that genipin induces apoptosis in human NSCLC H1299 cells, which is mediated via the activation of p38MAPK, leading to Bax expression, cytochrome c release, and the activation of caspases (-9 and -3).
P38 MAP Kinase Mediates Apoptosis After Genipin

Materials and Methods
Materials and cell culture
Genipin was purchased from Haikang Biotechnology, Ltd. (Chengdu, China) and dissolved in distilled water at 20 mM as a stock solution. Antibodies, anti-phosphor-ATF-2, anti-β-actin, anti-phosphor-p38MAPK, anticytochrome c, anti-cleaved poly ADP-ribose-polymerase (PARP), anti-Bcl-2, anti-phosphor-JNK, and anti-phosphor-c-Jun were obtained from Cell Signal Technology (Beverly, MA, USA). Bax antibody was from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The One-step Terminal Deoxynucleotidyltransferase dUTP Nick End Labeling (TUNEL) apoptosis assay kit and Caspase-9 and Caspase-3 Activity Kits were acquired from Beyotime Institute of Biotechnology (Suzhou, China). The mitochondrial fractionation kit was purchased from Sangon Bitotech Co., Ltd. (Shanghai, China). Peroxidase-conjugated AffiniPure goat anti-rabbit immunoglobulin was from ZSGB-BIO Co., Ltd. (Beijing, China). PVDF paper and the enhanced chemiluminescence (ECL) western blot detection system were purchased from Millipore Co. (Billerica, MA, USA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), Triton X-100, Tris base, SDS, acrylamide, bisacrylamide, ammonium persulfate, and TEMED were from Amresco Co. (Solon, OH, USA). All stock solutions were stored at 4°C or −20°C. All other chemicals were of analytical grade. H1299 cells were from the transplantation and immunization lab, West China Hospital of Sichuan University (Chengdu, China). H1299 cells were cultured in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% (v/v) heat-inactivated fetal bovine serum and antibiotics (100 units/ml of penicillin and 100 μg/ml of streptomycin) and maintained at 37°C in a humidified air atmosphere with 5% CO 2 .
Cytotoxicity assay
To detect the survival of cells after treatment, a standard cell growth assay was performed using the MTT reduction assay (30) . Briefly, cells were seeded at a density of 5 × 10 3 cells/well in 96-well plates. Then they were incubated with different concentrations of genipin (200, 300, 400, 500 μM) for 24 h, 20 μl MTT was added to each well and the cells were incubated at 37°C for 4 h. Finally, 150 μl dimethyl sulfoxide (DMSO) was added. The absorbance was then measured at 570 nm by a microplate reader (Thermo Fisher Scientific, Vantaa, Finland).
TUNEL assay
Apoptotic cells were assessed by measuring DNA fragmentation in a standard TUNEL assay following the instructions with the kit. In brief, cells were permeabilized with 0.1% Triton X-100 for 2 min on ice, reacted with TdT enzyme, and stained with FITC-dUTP for 1 h at 37°C in dark. The TUNEL-positive cells were imaged under a fluorescent microscope and the cells with green fluorescence were defined as apoptotic cells.
Western blot analysis
For detection of various proteins, the untreated and genipin-treated whole-cell extracts were lysed in lysis buffer (250 mM NaCl, 10 mM Tris, pH 7.4, 1 mM ethylene diamine tetraacetic acid (EDTA), 1% Triton X-100, 1 mM phenylmethanesulfonyl fluoride (PMSF), 0.01 mg/ml aprotinin, 0.01 mg/ml leupeptin). Whole cell lysates were clarified by centrifugation at 12,000 × g for 10 min at 4°C. The amounts of protein were normalized by the Bradford method. Equal amounts of total proteins were loaded to 10% -15% SDS-PAGE gels, electrophoresis carried out, and the separated proteins were subsequently electro-transferred on to PVDF membranes. Then the membranes were blocked with 5% nonfat milk in TSB-T buffer (100 mM Tris-HCl, pH 7.5, 0.9% NaCl, 0.05% Tween-20), probed with various primary antibodies (1:1000) overnight at 4°C, and secondary antibodies for 1 h. Then the membrane was washed and the bands were examined by a Bio-Rad ChemiDoc XRS imager (Bio-Rad, Hercules, CA, USA) with the ECL western blot detection system. The densities of bands were determined by densitometry using Quantity One software (Bio-Rad).
Analysis of cytochrome c release
For the mitochondrial cytochrome c release assay, a mitochondrial fractionation kit was used to separate mitochondrial and cytosolic fractions according to manufacturer's protocols. Ten million cells were resuspended with ice-cold Mito-cyto isolation buffer and homogenized 50 times. The homogenate was centrifuged at 3,000 rpm for 10 min at 4°C. The supernatants were collected in a new ice-cold tube and then centrifuged at 12,000 rpm for 30 min at 4°C. The supernatant and pellet were saved as the cytosolic fraction and intact mitochondria, respectively. Before western blot analysis of the cytosolic fraction was performed, protein concentration was measured after fractionation.
Caspase activity
The activities of caspase-9 and caspase-3 were measured using the Caspase Activity Kit according to the manufacturer's instructions. Briefly, supernatants from lysates of cells treated with 400 μM genipin were incubated at 37°C with Ac-LETD-ρNA or Ac-DEVD-ρNA in a reaction buffer for 2 h. The release of ρNA was qualified by determining the absorbance at 405 nm using a spectrophotometer. The enzymatic activity is represented as ΔA 405 /(min·mg protein).
Cell cycle analysis
For cell cycle and apoptosis analysis by flow cytometry, cells were treated with different concentrations of genipin for 24 h. Cells were then harvested and washed twice with ice-cold PBS. After the cells were fixed with 70% ethanol at 4°C overnight and treated with propidium iodide (PI, 50 μg/ml) and RNase A (100 μg/ml) at 37°C for 40 min, samples were analyzed by flow cytometry (FACScalibur; BD Biosciences, San Jose, CA, USA). The sub-G 1 population was scored from hypodiploid DNA content. Data were analyzed using ModFit LT V3.2 software.
Inhibitor assay
To investigate the effect of MAPK inhibitors on genipin-induced cell cycle arrest and apoptosis, H1299 cells were cultured with JNK inhibitor (20 μM SP600125) and p38MAPK inhibitor (20 μM SB203580), respectively, for 2 h. Then 300 μM genipin was added for the indicated time periods.
Statistical analyses
All data were presented as the mean ± S.D. of at least three independent experiments. One-way analysis of variance (ANOVA) was used for multiple comparison followed by Dunnett's test or the Bonferroni test. A probability value less than 0.05 was considered statistically significant.
Results
Genipin inhibits cell growth in H1299 cells
Genipin has been reported to show anti-tumor activity in many human cell lines (11 -15) . In our study, we confirmed that genipin also reduced cell viability in H1299 cells by using the MTT assay. After the cells were exposed to increasing concentrations of genipin for 24 h, cell viability significantly reduced from 75% to 31% (Fig. 1) . The IC 50 of genipin in H1299 cells was 351.5 μM. Then further experiments were conducted on H1299 cells exposed to 300 or 400 μM genipin according to the specific experiment. The results show that genipin exhibits the anti-proliferative effect in a dose-dependent manner in H1299 cells.
Genipin induces G 2 /M arrest and apoptosis in H1299 cells
To investigate the mechanism associated with genipininduced loss of cell proliferation, the effects of genipin treatment on cycle arrest and apoptosis were examined. Cells were treated with various concentrations of genipin for 24 h and then harvested for cell cycle analysis by flow cytometry after PI staining. Genipin induced G 2 /M arrest ( Fig. 2A ) that was consistent with an earlier report (13) , further demonstrating genipin's effect on cell Through flow cytometry, we also found that genipin treatment resulted in a marked increase in accumulation of sub-G 1 cells in a dose-dependent manner (Fig. 2B) . In order to ascertain the induction of cell death by genipin, the TUNEL assay, which shows characteristic chromatin condensation and nuclear fragmentation, was performed. As shown in Fig. 2C , a time-dependent increase in the percentage of TUNEL-positive cells was observed. In addition, by using the PARP cleavage assay, we further found that the cytotoxicity was due to apoptosis (Fig. 2D) . These results together indicate that genipin induces apoptosis of H1299 cells.
Genipin induces apoptosis through the mitochondrial cellular execution pathway
Various proteins are involved in the execution of apoptosis. Two of the most extensively studied are the caspases (31) and the Bcl-2 family (32). To evaluate the contribution of the mitochondrial pathway to the induction of apoptosis by genipin, we examined the activities of caspase-9 and caspase-3 and the release of cytochrome c into the cytosol. Data from a time kinetic study of caspases indicated that caspase-9 and caspase-3 were activated upon genipin treatment. As seen in Fig. 3A , genipin induced a significant increase in caspase-9 activity, approximately from 1.9-fold at 2 h to 27-fold at 16 h, and the activity of caspase-3 also substantially increased 14.8-and 12-fold of that in the control group at 8 and 16 h, respectively. Interestingly, the activity of caspase-3 peaked at 8 h earlier than caspase-9 which peaked at 16 h. The reason for this phenomenon is that activated caspase-3 acts on caspase-9 processing in a feedback amplification loop that results in complete activation of caspase-9 in various types of apoptosis and programmed cell death during development (33) .
Next, the subcellular location of cytochrome c, which normally resides in the mitochondria but is released into the cytoplasm following exposure of cells to certain apoptotic stimuli, has been suggested to participate in activating the cell death process (34) . As shown in Fig. 3B , addition of genipin to H1299 cells caused the accumulation of cytochrome c in the cytosolic fraction. Genipin also upregulated the expression of pro-apoptotic protein Bax and downregulated the anti-apoptotic protein Bcl-2 ( Fig. 3C ) followed by release of cytochrome c (Fig. 3B ) and the activation of caspase-9 and -3 ( Fig. 3A) , in agreement with previous studies suggesting that Bcl-2 family mediates mitochondrial dysfunction (32) . These results suggest that mitochondrial dysfunction-mediated cytochrome c release and subsequent activation of caspases are involved in the process of genipin-induced apoptotic cell death in H1299 cells.
Genipin activates p38MAPK pathway but not JNK pathway in H1299 cells
To investigate a potential involvement of MAPKs in genipin-induced apoptosis, we first examined the activation status of JNK and p38MAPK by western blotting with antibodies specific to the phosphorylated forms of theses kinases. Treatment of cells with genipin resulted in a dramatic dose-dependent increase of the phosphorylated form of p38MAPK, indicating the activation of p38MAPK in H1299 cells. In contrast, induction of p-JNK could not be observed in H1299 cells treated with genipin compared with the control treatment (Fig. 4A) . Moreover, phosphorylation of c-Jun, a major target of JNK, which is a signal of JNK activation (35) , was reduced upon the treatment of genipin (Fig. 4A) .
Activation of p38MAPK during genipin-induced apoptosis was further confirmed by the use of the JNK inhibitor SP600125 (36) and the p38MAPK inhibitor SB203580 (37) . Upon the TUNEL analysis, SB203580 notably suppressed the formation of clearly visible apoptotic bodies in genipin-treated cells (Fig. 4B) . In addition, the activation of the p38MAPK signaling cascade was corroborated by western blot analysis using phosphor-ATF-2 (Fig. 4C) , which is one of the targets for p38MAPK in the downstream signaling. Taken together, these data suggest a critical role for p38MAPK in genipin-induced apoptosis.
Role of p38MAPK in mediating Bax expression and cytochrome c release in genipin-treated cells
It has been shown that p38MAPK acts at early step(s) prior to dysfunction of mitochondria during apoptotic cell death in several model systems (38) . We next investigated whether the upregulation of Bax, downregulation of Bcl-2, and cytochrome c release in response to genipin treatment were dependent on p38MAPK activation. As shown in Fig. 3B , inhibition of p38MAPK by treatment with SB203580 effectively reduced the protein level of cytochrome c. Besides, the pretreatment of SB203580 markedly diminished genipin-evoked the upregulation of Bax when cells were treated for 24 h and 48 h (Fig. 5) , while the expression of Bcl-2 did not change (data not shown), which is consistent with Mandal et al.'s report (29) . In addition, the unsteady inhibition of Bax we observed with SP600125 at 24 h in genipin-treated cells may be due to the partial p38 pathway inhibition, and this inhibitory activity is possibly due to SP600125's inhibition of MKK3 and MKK6 enzyme activity (36) . Although SP600125 exhibits a slightly inhibitory effect in the expression of Bax when cells were treated for 24 h, the accumulation of Bax protein in response to genipin was not affected by the JNK inhibitor in cells treated for 48 h.
Discussion
Apoptosis, programmed cell death, is known to be essential to develop and maintain homeostasis during cell growth and elimination of damaged cells in multicellular organisms and is also a process of central importance in the prevention of tumor development (39) . It has been suggested that the induction of apoptosis and cell cycle inhibition are common mechanisms proposed for the anticancer effects of genipin. In line with these previous studies, we also found marked increase in accumulation of sub-G 1 cells and percentage of TUNELpositive cells, cleavage of PARP, and G 2 /M phase arrest in genipin-treated NSCLC H1299 cells.
Apoptosis can be induced via two distinct intracellular Fig. 3 . Genipin induces apoptosis through the mitochondrial cellular execution pathway. A) H1299 cells were treated with 400 μM genipin for the indicated time periods. Cell lysates were prepared and enzymatic activities of caspase-9 and -3 were determined by a spectrophotometer as described in "Materials and Methods". B) Cells were treated with 300 μM genipin or vehicle for 24 h in the absence (control) or presence of the p38MAPK inhibitor SB203580 (20 μM). Cytosolic cytochrome c was detected by western blot analysis. C) For the detection of Bax and Bcl-2, cells were treated with various concentrations of genipin as indicted in the figure. Cell lysates were subjected to SDS-PAGE followed by immunoblot analysis. Densitometry shows data from three experiments. Data are reported as means ± S.D., *P < 0.05, **P < 0.01 and # P < 0.05, ## P < 0.01 versus control (ANOVA with Dunnett's multiple comparison test), respectively. signaling pathways, the death receptor-mediated or the mitochondrial activation-mediated pathway (32, 40, 41) . The former pathway is triggered by ligation of death receptors such as Fas and TNFR, while the mitochondrial pathway responds to anticancer drugs and multiple classes of environmental stress. During the apoptotic process, the pro-apoptotic Bcl-2 members, such as Bax, redistribute from the cytosol to mitochondria followed by the increased membrane permeability. Due to this event, the released mitochondrial cytochrome c participates in the process leading to caspase-9 activation, followed by activation of caspase-3 (42) . In genipintreated FaO rat hepatoma cells, the release of cytochrome c from mitochondria to cytosol is observed, which suggests that genipin-induced apoptosis involves the mitochondrial apoptotic pathway (11) . Similarly, genipin treatment results in a sustained accumulation of Bax protein in Hela cells (13) . In line with these recent studies, upregulation of the pro-apoptotic protein Bax, downregulation of anti-apoptotic protein Bcl-2 (Fig. 3C) , increased levels of cytosolic cytochrome c (Fig. 3B) , and activation of caspase-9 and -3 ( Fig. 3A) were observed in the present study. These data indicate that genipin induces mitochondrial activation-mediated apoptotic cell death in NSCLC H1299 cells.
It has been suggested that p38MAPK is positively implicated in induction of apoptosis in response to various stress signals, including tumor necrosis factor-α, interlrukin-1, UV irradiation, hyperosmotic stress, and chemotherapeutic drugs (43 -45) . Consistent with these findings, we also found that genipin treatment induced activation of p38MAPK and that inhibition of p38MAPK effectively attenuated genipin-induced apoptotic cell death. However, other reports suggest that genipininduced apoptotic cell death is associated with a rapid increase in JNK activity, but p38MAPK is not significantly activated (11 -14) . Except for these observations, no report on the p38MAPK signaling pathway activated by genipin is available in literature. Such differential effects observed from one study to another could reflect cell type or treatment specificity. The mechanism underlying such a discrepancy in different cell types remains to be investigated. However, our data provide the first evidence that genipin-induced apoptosis is associated with p38MAPK. This is supported by many observations including genipin-induced enhanced phosphorylation of p38MAPK (Fig. 4A) and followed by the activation of phosphorylated ATF-2 (Fig. 4D) , which is one of the targets for p38MAPK. Moreover, inhibition of p38MAPK using the specific inhibitor SB203580 resulted in a dramatic protection of these cells from genipin-induced apoptosis (Fig. 4B) , suggesting that genipin-induced cell death is dependent on the p38MAPK signaling pathway that plays a critical role in inducing apoptosis.
Recently it has been demonstrated that p38MAPK induces apoptosis by regulating the conformation of Bax in response to various stimuli, including UVB, cisplatin, taxol, and nocodazole (28, 38, 46, 47) . In this study, we found that inhibition of p38MAPK inhibited the accumulation of Bax protein (Fig. 5 ). This result is consistent with previous studies that NH 2 and COOH termini of Bax are rich in glycine and hydroxyl amino acids such as serine and threonine (48, 49) , which are potential targets of p38MAPK, and are critical for regulating the subcellular distribution of Bax (27) . In human promonocytic cells, the rapid phosphorylation of p38MAPK suggests that this kinase plays an early role in the regulation of the cadmium-provoked apoptosis (50) . Moreover, inhibition of p38MAPK almost completely prevents radiation-induced Bax translocation to the mitochondria, release of cytochrome c into the cytosol, caspase-3 activation, and PARP cleavage (50) . These results are in good agreement with the fact that p38MAPK mediates dysfunction of mitochondria and subsequent induces caspase activation in several cell types (38, 50) .
Lung cancer is the leading cause of death among human malignancies. NSCLC cells account for 80% of lung cancer cases and is among the most threatening of human malignancies due to its disappointing response to treatment. It has been reported that p53 gene status exerts different effects on DNA damage-induced cell death and chemosensitivity to various chemotherapeutic agents in NSCLC cells (51) . Therefore, H1299 (p53-null type) shows resistance to conventional cancer treatments, such as ionizing radiation (IR) and cisplatin, while the other cell line like H460 (p53 wild-type), is sensitive to treatment with these agents (52) . However, genipin could exhibit a strong apoptotic cell death effect in H1299 cells, human leukemia K562 (p53-deficient type) cells (14) as well as Hela cells (p53 wild-type) (13) through different pathways of p53 independently or dependently. Additionally, because of the deletion of p53, H1299 cells show high basal levels of NF-κB DNA binding activity, which acts as an anti-apoptotic factor and is involved in proliferation and chemo-resistance of cancer cells (53) . Furthermore, genipin has been reported as a natural inhibitor with anticancer potential, which could block the degradation of IκBβ protein and further inhibit NF-κB signaling (54) . These findings might explain why H1299 is sensitive to the treatment of genipin, but the exact mechanisms need to be investigated. Given H1299 cells' resistance to conventional cancer therapy, genipin should be considered as a promising chemotherapeutic agent for the treatment of H1299 cells.
In conclusion, our data outline the potent anti-tumor effects of the traditional natural compound genipin on NSCLC H1299 cells. We demonstrated that genipin induced cell cycle arrest at the G 2 /M phase and apoptosis that was accompanied with upregulation of Bax, downregulation of Bcl-2, release of cytochrome c, and activation of caspase-9 and -3. Further investigations showed that genipin-evoked apoptosis was reversed by pretreatment with a p38MAPK inhibitor (SB203580). In line with this observation, SB203580 attenuated the activation of Bax and release of the mitochondrial cytochrome c into the cytosol in genipin-treated cells. Taken together, our data show that p38MAPK-mediated activation of pro-apoptotic protein Bax promotes genipin-induced apoptotic cell death via the mitochondrial death cascade in NSCLC H1299 cells.
